CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

Hu, Wanghong ; Zi, Zhenguo ; Jin, Yanling ; Li, Gaoxin ; Shao, Kang ; Cai, Qiliang ; Ma, Xiaojing ; Wei, Fang

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.365-377 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível